南达科他州堕胎药广告禁令暂缓执行 法院禁制令维持
据南达科他州公共广播电台 10 月 6 日的日播新闻报道，阻止执行该州 HB1274 法案（限制堕胎药广告的法律）的法院禁令继续有效。这是挑战该法的生殖健康组织 Mayday Health 的一次胜利。
HB1274 由州议会通过，旨在禁止或严格限制州内堕胎药广告，是罗伊案被推翻后各州堕胎限制浪潮的一部分。运营堕胎药信息宣传的 Mayday Health 提起诉讼，认为该法针对受保护的言论，违反第一修正案。
联邦法官认同这一主张，认定该法很可能经不起合宪性审查，发布初步禁令，在案件审理期间暂停执行。州政府已提起上诉，但禁令目前仍然有效。
此案在全国范围内备受关注，因为其他几个州也在考虑出台类似的堕胎药广告限制。法律专家表示，判决结果可能决定各州在规范生殖健康言论方面能走多远。
（来源：南达科他州公共广播电台）
Injunction Blocking South Dakota's Abortion-Pill Ad Law Remains in Effect
A court injunction blocking enforcement of South Dakota's HB 1274 — a law restricting advertising for abortion pills — remains in effect, South Dakota Public Broadcasting reported on its October 6 daily newscast. The ruling is a win for Mayday Health, the reproductive health organization that challenged the law.
HB 1274, passed by the state legislature, sought to ban or severely restrict advertising of abortion medication in the state, part of a broader wave of post-Roe abortion restrictions. Mayday Health, which operates an informational campaign about abortion pill access, sued, arguing the law violates the First Amendment by targeting protected speech about legal health care.
A federal judge agreed, finding that the state was unlikely to survive constitutional scrutiny and issuing a preliminary injunction halting enforcement while the case proceeds. The state has appealed, but the injunction remains in place.
The case is being closely watched nationally, as several other states have considered similar restrictions on advertising for abortion medication. Legal experts say the outcome could shape how far states can go in regulating speech about reproductive health care.
(Source: South Dakota Public Broadcasting)
图片来源：w_lemay，CC BY-SA 2.0（Wikimedia Commons）
